NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
15 hedge funds and large institutions have $677K invested in NeuBase Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$156K | |
| 2 | +$96.3K | |
| 3 | +$55K | |
| 4 |
SSB
Sandy Spring Bank
Olney,
Maryland
|
+$1K |
| 5 |
BlackRock
New York
|
+$45 |
Top Sellers
| 1 | -$16K | |
| 2 | -$12K | |
| 3 | -$11K | |
| 4 |
VF
Virtu Financial
New York
|
-$11K |
| 5 |
GBA
Garrison Bradford & Associates
New York
|
-$9K |